Immobilization of confined European bison with a medetomidine - zolazepam/tiletamine - butorphanol combination using readily available veterinary medicinal products

Authors

  • Johannes Riedl European Bison Conservation Center – Regional Office South Germany, Augsburg, Germany, Wisentgehege Donaumoos, Germany
  • Christina Heermann Tierarztpraxis Heermann, Petershausen, Germany

Keywords:

European bison, immobilization, medetomidine, zolazepam/tiletamine, butorphanol, jab stick

Abstract

Various protocols have been used to immobilize European bison in recent years. Nevertheless, availability, human toxicity, animal side effects, costs and legal obstacles continue to cause problems for breeders of the European Bison. We have therefore applied an immobilization protocol that is essentially based on medetomidine, zolazepam/tiletamine and butorphanol using products, which are readily available on the market. The basic prerequisite for the application is the ability to separate individual animals and apply larger volumes using a jab stick. This paper shows the results of 21 immobilizations of animals that were intended for transport to other breeding enclosures or for reintroduction projects between 2019 and 2021. The combination is suitable for most immobilization reasons and meets all requirements for safe and animal-friendly immobilization.

 

Downloads

Published

2022-09-06

How to Cite

Riedl, J., & Heermann, C. (2022). Immobilization of confined European bison with a medetomidine - zolazepam/tiletamine - butorphanol combination using readily available veterinary medicinal products. European Bison Conservation Newsletter, 14, 11–22. Retrieved from http://ojs.wisent.org/index.php/czasopismo/article/view/100

Issue

Section

Peer-reviewed articles

Categories